stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G - Aligos Therapeutics, Inc. | StockGist | StockGist
Companies
ALGS
SCHEDULE 13G
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ALGS
SCHEDULE 13G
SCHEDULE 13G
Beneficial Ownership
Aligos Therapeutics, Inc.
Filed May 15, 2025
Accepted May 14, 2025, 8:00 PM ET
ALGS
CIK 0001799448
View on SEC.gov
Company Profile
0001172661-25-002361
Beneficial Ownership Report
Passive Investment
Shares Owned
412,000
Reporting Person
Aligos Therapeutics, Inc.
Person Type
IA
CUSIP: 01626L204
Amendment History
4 filings
SCHEDULE 13G
Original
Viewing
May 15, 2025
0001172661-25-002361
SCHEDULE 13G/A
Amendment 1
Feb 12, 2025
0000902664-25-000862
SCHEDULE 13G/A
Amendment 2
Feb 14, 2025
0001172661-25-001230
SCHEDULE 13G/A
Amendment 3
Latest
May 15, 2025
0000935836-25-000358